Why Pfizer ended testing on once-daily weight-loss pill treatment

From TODAY.

Pfizer announced it is ending its development of a once-daily weight-loss pill treatment for obesity. It comes after a participant in one of the trials experienced a possible drug-induced liver injury and recovered after the medication was stopped.

» Subscribe to TODAY: https://www.youtube.com/@TODAY

About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series.

Connect with TODAY Online!
Visit TODAY’s Website: https://www.today.com/
Find TODAY on Facebook: https://www.facebook.com/today
Follow TODAY on Twitter: https://twitter.com/TODAYshow
Follow TODAY on Instagram: https://www.instagram.com/todayshow/

» Stream TODAY All Day: https://www.today.com/allday
About: TODAY All Day is a 24/7 streaming channel bringing you the top stories in news and pop culture, celebrity interviews, cooking, and more. All in one place.

#pfizer #obesity #weightloss